Armata Pharmaceuticals, Inc. (ARMP) Earnings History
Net Loss33 years of earnings data (1993–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Armata Pharmaceuticals, Inc. (ARMP) Earnings Overview
As of June 23, 2026, Armata Pharmaceuticals, Inc. (ARMP) reported trailing twelve-month net income of -$283M, reflecting -823.1% year-over-year growth. The company earned $-7.74 per diluted share over the past four quarters, with a net profit margin of -3544.0%.
Looking at the long-term picture, ARMP's historical earnings data spans multiple years. The company achieved its highest annual net income of $23M in fiscal 2014.
Armata Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PHGE (-$48M net income), LSTA (-$16M net income, -9756.5% margin), SIGA ($20M net income, 24.6% margin), ARMP has comparable earnings metrics. Compare ARMP vs PHGE →
ARMP Earnings vs Peers
Earnings metrics vs comparable public companies
ARMP Historical Earnings Data (1993–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$174M | -818.8% | -$31M | $-4.80 | -3544.0% | -636.7% |
| 2024 | -$19M | +72.6% | -$42M | $-0.52 | -365.6% | -820.2% |
| 2023 | -$69M | -87.0% | -$41M | $-1.91 | -1524.5% | -902.8% |
| 2022 | -$37M | -59.4% | -$37M | $-1.08 | -670.2% | -670.8% |
| 2021 | -$23M | -4.4% | -$24M | $-0.96 | -517.5% | -532.5% |
| 2020 | -$22M | -13.9% | -$22M | $-1.35 | -2695.1% | -2623.0% |
| 2019 | -$19M | -60.9% | -$19M | $-2.43 | - | - |
| 2018 | -$12M | +5.7% | -$13M | $-8.90 | - | - |
| 2017 | -$13M | +31.9% | -$16M | $-27.34 | -11163.5% | -14048.7% |
| 2016 | -$19M | -3550.8% | -$23M | $-345.80 | -7245.4% | -8991.5% |
| 2015 | $-516,000 | -102.2% | -$10M | $-278.60 | -108.6% | -2153.1% |
| 2014 | $23M | +135.8% | -$14M | $-326.20 | 5650.1% | -3449.9% |
| 2013 | -$65M | -5718.3% | -$15M | $-4479.97 | -19871.7% | -4611.1% |
| 2012 | -$1M | +94.6% | -$4M | $-161.76 | -167.2% | -606.0% |
| 2008 | -$21M | -28.5% | -$21M | $-7270.18 | -237.7% | -242.8% |
| 2007 | -$16M | +52.6% | -$17M | $-6842.17 | -156.1% | -160.2% |
| 2006 | -$34M | -77.0% | -$37M | $-24313.30 | -344.6% | -372.4% |
| 2005 | -$19M | -34.7% | -$19M | $-15697.47 | -279.3% | -281.5% |
| 2004 | -$14M | +3.9% | -$15M | $-12561.23 | -147.7% | -157.2% |
| 2003 | -$15M | +37.6% | -$14M | $-1290.16 | -105.4% | -98.1% |
| 2002 | -$24M | +12.5% | -$18M | $-2600.00 | -122.9% | -95.2% |
| 2001 | -$27M | +43.0% | -$29M | $-3100.00 | -143.9% | -151.5% |
| 2000 | -$48M | -78.5% | -$46M | $-6300.00 | -417.9% | -401.7% |
| 1999 | -$27M | -206.9% | -$11M | $-4200.00 | -392.6% | -163.2% |
| 1998 | -$9M | +38.7% | -$9M | $-1633.19 | -120.8% | -126.4% |
| 1997 | -$14M | +45.4% | -$15M | $-3515.72 | -1577.8% | -1655.6% |
| 1996 | -$26M | -162.6% | -$12M | $-7924.41 | -1130.4% | -526.1% |
| 1995 | -$10M | -17.9% | -$10M | $-4700.85 | -9900.0% | -10400.0% |
| 1994 | -$8M | -64.7% | -$8M | $-7000.00 | -2100.0% | -2075.0% |
| 1993 | -$5M | - | -$5M | $-195.58 | -5100.0% | -5400.0% |
Download Data
Export ARMP earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
33+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ARMP — Frequently Asked Questions
Quick answers to the most common questions about buying ARMP stock.
What is ARMP earnings per share (EPS)?
ARMP trailing twelve-month (TTM) diluted EPS is $-7.74, reflecting -823.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1993 to 2025 is available in the table on this page.
What is Armata Pharmaceuticals, Inc.'s net income?
Armata Pharmaceuticals, Inc. (ARMP) trailing twelve-month net income is $-283M as of 2025. Earnings declined -823.1% year-over-year.
Is ARMP profitable?
ARMP is not currently profitable on a TTM basis, reporting a net loss of $-283M. Net margin is -3544.0%. Investors should monitor for a return to profitability.
What is ARMP's earnings growth rate?
ARMP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1993 to 2025.
What are ARMP's profit margins?
Armata Pharmaceuticals, Inc. net profit margin is -3544.0%, operating margin is -636.7%, and gross margin is +68.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is ARMP growing earnings?
ARMP earnings are declining — EPS fell -823.1% year-over-year. TTM net income dropped to $-283M. This contrasts with the 5-year CAGR of N/A.
What was ARMP's best earnings year?
Armata Pharmaceuticals, Inc.'s highest annual net income on record is $23M, achieved in fiscal year 2014. Earnings history on this page spans 1993 to 2025 and includes all annual and quarterly figures.
What were ARMP's earnings last quarter?
ARMP's most recent reported quarter was Q1 2026. Net income was $-115M with diluted EPS of $-3.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.